Alternatives to Goldenrod Therapeutics, .
Goldenrod Therapeutics, . is a Biotech tool: developing novel therapeutics for rare and underserved diseases. Here are the 50 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Biotech companies to Goldenrod Therapeutics, .
Adaptam TherapeuticsNot ratedDeveloping novel therapeutics for rare genetic diseases with a focus on protein degradation.
Avidity BiosciencesNot ratedClinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.
Denali TherapeuticsNot ratedBiopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.
Manifold BioNot ratedAI-guided drug discovery platform for tissue-targeted medicines.
Cue Biopharma, .Not ratedDeveloping engineered biologics to harness the immune system for disease treatment.
TippingPoint BiosciencesNot ratedDeveloping novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.
Hexagon BioNot ratedDeveloping novel therapeutics by understanding the complex interplay of biological systems.
Amicus TherapeuticsNot ratedBiotechnology company focused on developing treatments for rare metabolic diseases.
Harmony Biosciences HoldingsNot ratedBiopharmaceutical company focused on developing and commercializing innovative treatments for rare neurological disorders.
Integra TherapeuticsNot ratedBiotech company developing next-generation gene writing tools for advanced therapies.
RezoluteNot ratedBiopharmaceutical company developing transformative therapies for rare metabolic diseases, focusing on hyperinsulinism.
C4 TherapeuticsNot ratedBiopharmaceutical company developing novel cancer therapies using targeted protein degradation.
ANI PharmaceuticalsNot ratedDiversified biopharmaceutical company focused on rare diseases, generics, and established brands.
Epicrispr BiotechnologiesNot ratedEpicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).
Editas MedicineNot ratedA clinical-stage biotechnology company developing transformative genome editing medicines for serious diseases.
CureVacNot ratedBiopharmaceutical company developing mRNA-based vaccines and therapeutics for infectious diseases and cancer.
Sutro BiopharmaNot ratedClinical-stage biopharma developing precisely designed cancer therapeutics using a proprietary cell-free protein synthesis platform.
Intellia TherapeuticsNot ratedA clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.
Nona BiosciencesNot ratedBiotechnology company specializing in antibody discovery and development with integrated 'Idea to IND' solutions.
Gene Bio MedicalNot ratedDevelops advanced gene editing and cell therapy solutions for rare genetic diseases.
Showing the next 20 closest matches. See the rest on the Goldenrod Therapeutics, . profile.
Sponsored rows are paid and labelled. Advertise on this page
